Recent CRBU News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/20/2024 08:07:04 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 08/20/2024 08:05:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/12/2024 12:03:02 PM
- Caribou Biosciences Appoints Tina Albertson, MD, PhD, as Chief Medical Officer • GlobeNewswire Inc. • 08/12/2024 12:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/06/2024 08:08:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/06/2024 08:07:26 PM
- Caribou Biosciences Reports Second Quarter 2024 Financial Results and Provides Business Update • GlobeNewswire Inc. • 08/06/2024 08:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/16/2024 08:01:48 PM
- Caribou Biosciences Announces Appointment of Terri Laufer, MD, to its Scientific Advisory Board • GlobeNewswire Inc. • 07/09/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/14/2024 08:03:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/03/2024 10:01:56 AM
- Caribou Biosciences Presents Encouraging Clinical Data from CB-010 ANTLER Phase 1 Trial in Second-line LBCL Patients at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting • GlobeNewswire Inc. • 06/02/2024 11:00:00 PM
- Caribou Biosciences to Host KOL Discussion with Webcast from the 2024 ASCO Annual Meeting and Participate in Upcoming Investor Conferences • GlobeNewswire Inc. • 05/30/2024 08:01:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2024 08:11:12 PM
- Caribou Biosciences Reports First Quarter 2024 Financial Results and Provides Business Update • GlobeNewswire Inc. • 05/07/2024 08:05:00 PM
- Caribou Biosciences to Participate in Upcoming Investor Conferences • GlobeNewswire Inc. • 05/01/2024 08:05:00 PM
- Caribou Biosciences to Present Initial Dose Expansion Data from CB-010 ANTLER Phase 1 Trial in r/r B-NHL at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting • GlobeNewswire Inc. • 04/24/2024 02:00:00 PM
- Caribou Biosciences Announces Oral Presentation on In Vivo Cas12a chRDNA Genome Editing at the 27th Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT) • GlobeNewswire Inc. • 04/15/2024 01:00:00 PM
- Caribou Biosciences Expands Clinical Development of CB-010 with FDA Clearance of IND in Lupus • GlobeNewswire Inc. • 04/04/2024 08:00:00 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 03/11/2024 09:08:46 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/11/2024 08:25:52 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/11/2024 08:22:42 PM
- Caribou Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update • GlobeNewswire Inc. • 03/11/2024 08:05:00 PM
- Caribou Biosciences to Present Preclinical Data on CB-012, an Allogeneic Anti-CLL-1 CAR-T Cell Therapy, at the American Association for Cancer Research (AACR) Annual Meeting • GlobeNewswire Inc. • 03/05/2024 09:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/22/2024 10:28:33 PM
PickleJar Unveils Latest Venue Managed Services Innovations in Upcoming Webinar • PKLE • Aug 23, 2024 1:11 PM
Element79 Gold Corp Provides Update on Nevada Portfolio • ELMGF • Aug 23, 2024 8:00 AM
Maybacks Adds Award Winning Show to Its Lineup Discusses Maybacks Opportunity • AHRO • Aug 22, 2024 11:30 AM
North Bay Resources Announces First Gold Concentrate at Mt. Vernon Gold Mine, Assays 12 oz/ton Gold, 17.5 oz/ton Platinum, and 8 oz./ton Silver, Sierra County, California • NBRI • Aug 22, 2024 10:28 AM
All Things Mobile Analytic, Inc. Reports Major Growth with Over $11 Million in Revenue • ATMH • Aug 22, 2024 7:19 AM
Unitronix Announces Strategic Entry into Cryptocurrency Space • UTRX • Aug 21, 2024 10:00 AM